Hoffmann-La Roche: all 2,744 studies
Page 20 of 28. Open to participants first (117), then studies with results posted, then the rest; newest registration first within each.
- Extension Study Evaluating the Safety and Efficacy of Subcutaneous Tocilizumab (RoActemra/Actemra) Administration in Systemic and Polyarticular-Course Juvenile Idiopathic ArthritisCompletedNCT02165345Phase 1
- A Two-part, Single-dose, Randomized Study to Evaluate the Safety of Supra-therapeutic Doses of RO7033877 and to Investigate the Effect of RO7033877 on the QTc IntervalCompletedNCT02165332Phase 1
- A Single Center Study to Evaluate the Penetration of RO7033877 Into the Lung in Healthy VolunteersCompletedNCT02165293Phase 1
- A Study to Investigate in Healthy Volunteers (Part 1) and in Patients With Type 2 Diabetes Mellitus (Part 2) the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Doses of RO6799477CompletedNCT02164266Phase 1
- A Study Evaluating the Efficacy and the Benefit of Integrated Personalized Diabetes Management (PDM) for Diabetic Patients.CompletedNCT02156349Not applicable
- A Phase 1 Clinical Study in Healthy Volunteers to Investigate the Drug-drug Interaction Between Multiple Doses of RO7033877 and Multiple Doses of Colistin Methanesulfonate Sodium (CMS)CompletedNCT02156323Phase 1
- An Observational Study of Avastin (Bevacizumab) in Patients With Ovarian CancerCompletedNCT02151370
- A Study Evaluating the Safety and Pharmacokinetics of DMUC4064A in Participants With Platinum-Resistant Ovarian Cancer or Unresectable Pancreatic CancerCompletedNCT02146313Phase 1
- Placebo-Controlled, Single and Multiple Ascending Subcutaneous Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BMS-986089 in Healthy Adult SubjectsCompletedNCT02145234Phase 1
- An Observational Study of BRAF Inhibitors Effectiveness in Patients With Newly Diagnosed Metastatic MelanomaCompletedNCT02143999
- Expanded Access Program (EAP): Allow Patients in the US With Idiopathic Pulmonary Fibrosis Access to PirfenidoneApproved for marketingNCT02141087
- A Randomized, Phase I, Cross-Over Study to Assess the Relative Bioavailability of Single-Dose Cobimetinib (GDC-0973) in Tablet vs. Capsule FormulationCompletedNCT02136524Phase 1
- A Study Investigating the Bioavailability of a High Concentration Liquid Formulation Versus a Reference Lyophilized Formulation of Gantenerumab in Healthy VolunteersCompletedNCT02133937Phase 1
- A Study Evaluating the Safety and Efficacy of Rituximab in Combination With Glucocorticoids in Participants With Wegener's Granulomatosis or Microscopic PolyangitisCompletedNCT02115997Phase 4
- European, Open-label, Prospective, Multinational, Multicenter Study in Adult Subjects With Type 1 or Type 2 Diabetes Previously on MDI or CSII Therapy. Subjects Home Setting is Considered Routine Practice.CompletedNCT02105103Not applicable
- A 2-Part Study to Evaluate the Safety of Supra-Therapeutic Doses of RO4602522 and to Investigate the Effect of RO4602522 on the QTc IntervalCompletedNCT02104648Phase 1
- A Study Evaluating the Perception of Insertion Pain With Accu-Chek FlexLink and FlexLink Plus Insulin Pump Devices Under Real Life Conditions in Diabetic Patients.CompletedNCT02103595Not applicable
- Multicenter, Post-marketing, Non-interventional, Observational Study in RA Patients Treated With RoActemra/Actemra (Tocilizumab)CompletedNCT02101307
- An Analysis of Treatment Patterns and Outcomes for Basal Cell Carcinoma (BCC) Cancer ParticipantsCompletedNCT02100111
- A Study Evaluating the Effects of Lebrikizumab on Airway Eosinophilic Inflammation in Participants With Uncontrolled AsthmaCompletedNCT02099656Phase 2
- A Study of the Safety and Pharmacokinetics of RO6839921, An MDM2 Antagonist, in Patients With Advanced Cancers, Including Acute Myeloid Leukemia.CompletedNCT02098967Phase 1
- Study of Oral RXDX-101 in Adult Patients With Locally Advanced or Metastatic Cancer Targeting NTRK1, NTRK2, NTRK3, ROS1, or ALK Molecular Alterations.CompletedNCT02097810Phase 1
- A Study Examining Maintenance Bevacizumab (Avastin®) Monotherapy in Participants With Advanced Lung AdenocarcinomaCompletedNCT02093000
- A Study of the Effect of Formulation and Tablet Hardness on the Bioavailability of Pictilisib in Healthy VolunteersCompletedNCT02092831Phase 1
- A Study Evaluating the Safety of Escalating Doses of DLYE5953A in Patients With Refractory Solid TumorsCompletedNCT02092792Phase 1
- An Observational Study Examining the Effect of Added MabThera Therapy in Patients With Untreated Chronic Lymphocytic LeukemiaCompletedNCT02080884
- A Study Evaluating the Effect of Formulation on the Bioavailability of Ipatasertib in Healthy VolunteersCompletedNCT02063581Phase 1
- Indoleamine 2,3-Dioxygenase (IDO) Inhibitor in Advanced Solid TumorsCompletedNCT02048709Phase 1
- Ability of Muscle Imaging and Motor Function Measure (MFM) to Detect Changes in Disease Progression in Ambulant Spinal Muscular Atrophy Patients Compared to Healthy Volunteers.CompletedNCT02044029
- An Observational Study of Patients' Perception of Treatment With Erythropoiesis-Stimulating Agents in Patients With Chronic Kidney Disease Not on Dialysis (PERCEPOLIS)CompletedNCT02042833
- A Study of SC Administration of Trastuzumab (Herceptin) by SID at Home in HER2-Positive EBC ParticipantsCompletedNCT02040935Phase 3
- A Study of the Efficacy and Safety of MetMAb Combined With Tarceva in Patients With Met-Positive Non-Small Cell Lung CancerCompletedNCT02031744Phase 3
- The Pharmacokinetics and Safety of Onartuzumab (MetMAb) in Chinese Patients With Locally Advanced or Metastatic Solid TumorsCompletedNCT02031731Phase 1
- A Study of RG1662 in Adults and Adolescents With Down Syndrome (CLEMATIS)CompletedNCT02024789Phase 2
- A Study of the Safety, Tolerability and Pharmacokientics of RO5545965 in Patients With Schizophrenia on RisperidoneCompletedNCT02019329Phase 1
- A Study Exmining the Effect of Multiple Doses of Bitopertin on the Single Dose Pharmacokinetics of Midazolam in Healthy Volunteers.WithdrawnNCT02019290Phase 1
- A Study Evaluating the Safety, Pharmacokinetics, and Pharmacodynamics of RO6864018 in Male, Healthy, Asian ParticipantsCompletedNCT02015715Phase 1
- A Phase 1b Study of Atezolizumab in Combination With Erlotinib or Alectinib in Participants With Non-Small Cell Lung Cancer (NSCLC)CompletedNCT02013219Phase 1
- A Study Assessing the Safety and Efficacy of Subcutaneous RoActemra/Actemra Alone or in Combination With Non-biologic Antirheumatics in Rhuematoid Arthritis Patients in Latin America With Inadequate Response to Non-biologic Antirheumatic Drugs.CompletedNCT02011334Phase 3
- Study of the Treatment of Algerian Patients With Early Rheumatoid ArthritisCompletedNCT02008266
- A Study to Evaluate Safety, Pharmacokinetics, and Efficacy of RO6895882 in Participants With Advanced and/or Metastatic Solid TumorsCompletedNCT02004106Phase 1
- A Single Ascending Dose Study Investigating the Safety, Pharmacokinetics and Pharmacodynamics of RO6836191 in Healthy Male Volunteers.CompletedNCT01995383Phase 1
- A Study to Evaluate the Safety and Pharmacology of DNIB0600A in Participants With Platinum-Sensitive Ovarian Cancer or Non-Squamous Non-small Cell Lung CancerCompletedNCT01995188Phase 1
- H.E.R.O.S. Study: An Observational Study of the Cardiac Safety of Herceptin (Trastuzumab) in Patients With HER2-Positive Breast CancerCompletedNCT01991340
- A Study of DNIB0600A in Comparison With Pegylated Liposomal Doxorubicin (PLD) in Participants With Platinum-Resistant Ovarian Cancer (PROC)TerminatedNCT01991210Phase 2
- A Study of GDC-0853 in Patients With Resistant B-Cell Lymphoma or Chronic Lymphocytic Leukemia.CompletedNCT01991184Phase 1
- An Observational Safety Study in Zelboraf (Vemurafenib)-Treated Patients With BRAF-V600 Mutation-Positive Unresectable or Metastatic Melanoma (ZeSS)CompletedNCT01990248
- Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Intravenous and Multiple Subcutaneous and Intravenous Doses of PF-06480605 in Healthy Subjects.CompletedNCT01989143Phase 1
- Study of Atezolizumab in Combination With Cobimetinib in Participants With Locally Advanced or Metastatic Solid TumorsCompletedNCT01988896Phase 1
- A Study of Quilizumab Versus Placebo in Patients With Refractory Chronic Spontaneous UrticariaCompletedNCT01987947Phase 2
- A Two Part Study of RO6870810. Dose-Escalation Study in Participants With Advanced Solid Tumors and Expansion Study in Participants With Selected MalignanciesCompletedNCT01987362Phase 1
- A Study of MEHD7945A and Cobimetinib in Patients With Locally Advanced or Metastatic Cancers With Mutant KRASCompletedNCT01986166Phase 1
- A Study of the Elimination, Pharmacokinetics, and Metabolism of RO5424802CompletedNCT01981005Phase 1
- A Study of MHAA4549A in Healthy Volunteers in an Influenza Challenge ModelCompletedNCT01980966Phase 2
- A Study to Evaluate the Effect of Particle Size, Formulation and Food on the Pharmacokinetics of GDC-0032 in Healthy VolunteersCompletedNCT01980953Phase 1
- An Observational Study of Hemoglobin Stability in Chronic Kidney Disease Patients on Dialysis Treated With Mircera (Methoxy Polyethylene Glycol-epoetin Beta)CompletedNCT01974271
- Safety, Tolerability, and Pharmacokinetics of Onartuzumab Combined With Vemurafenib and/or Cobimetinib in Cancer PatientsWithdrawnNCT01974258Phase 1
- A Study of the Effect of Multiple Doses of Itraconazole and Fluoxetine on the Pharmacokinetics of a Single Dose of RO5285119 in Healthy SubjectsCompletedNCT01967979Phase 1
- A Bioavailability and Pharmacokinetic Study of GDC-0032 in Healthy VolunteersCompletedNCT01967966Phase 1
- A Study of Participant Satisfaction and Safety With Subcutaneously Administered Trastuzumab (Herceptin) in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Early Breast CancerCompletedNCT01964391Phase 3
- A Non-Interventional Study of Patients With Persistent Symptoms of Schizophrenia to Describe Medical Resource Utilization and Burden of IllnessCompletedNCT01959659
- A Study of Trastuzumab Subcutaneous in Participants With Human Epidermal Growth Factor Receptor-2 (HER2) Positive Early Breast CancerCompletedNCT01959386
- A Non-Interventional Study of RoActemra/Actemra (Tocilizumab) Treatment in Patients With Rheumatoid ArthritisCompletedNCT01952509
- A Study of RO6811135 in Patients With Type 2 Diabetes Who Are Inadequately Controlled With MetforminWithdrawnNCT01951183Phase 2
- A Study to Measure Serum Periostin, Asthma-Related Biomarkers and Response to Prednisolone in Adult and Adolescent Patients With Severe Oral Corticosteroid-Dependent AsthmaCompletedNCT01948401Phase 2
- A Study of RO6867461 Administered in Single- and Multiple-Ascending Doses in Patients With Wet Age-Related Macular DegenerationCompletedNCT01941082Phase 1
- An Interventional Study of Avastin (Bevacizumab) in Patients With Advanced/Metastatic Epithelial Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal CancerCompletedNCT01932125Phase 4
- A Screening Study To Assess The Cognition Status in Healthy VolunteersCompletedNCT01926873
- A PET Study With RO5545965 in Healthy Male VolunteersCompletedNCT01923025Phase 1
- A Retrospective, Observational Study of RoActemra/Actemra (Tocilizumab) in Clinical Practice in Patients With Rheumatoid ArthritisCompletedNCT01921478
- A Screening Protocol to Assess Adults and Adolescents With Down Syndrome for Eligibility For Upcoming Study of RG1662 (Study BP27832)CompletedNCT01920633
- U-Act-After: An Observational Study on Long-Term Efficacy of Tight Control RoActemra/Actemra (Tocilizumab) and/or Methotrexate in Patients With Early Rheumatoid Arthritis Who Have Participated in the U-Act-Early Study (ML22497)CompletedNCT01918267
- A Study to Evaluate Lumretuzumab in Combination With Pertuzumab and Paclitaxel in Participants With Metastatic Breast Cancer Expressing Human Epidermal Growth Factor Receptor (HER) 3 and HER2 ProteinCompletedNCT01918254Phase 1
- A Study of RO6870868 in Healthy VolunteersCompletedNCT01911611Phase 1
- A Study of MEHD7945A in Combination With Cisplatin and 5-Fluorouracil (5-FU) or Paclitaxel and Carboplatin in Participants With Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck (R/M SCCHN)CompletedNCT01911598Phase 1
- A Study to Collect Blood Samples From Patients With Spinal Muscular Atrophy for Biomarker AnalysisCompletedNCT01910168
- A Study of Subcutaneously Administered Tocilizumab in Participants With Systemic Juvenile Idiopathic ArthritisCompletedNCT01904292Phase 1
- A Study of Setrobuvir in Combination With Pegasys (Peginterferon Alfa-2a) and Copegus (Ribavirin) in Patients With Genotype 1 Chronic Hepatitis CCompletedNCT01903954Phase 2
- An Observational Study of Induction Therapy With Fuzeon (Enfuvirtide) in Combination With Antiretroviral Drugs in Patients With HIV-1 InfectionCompletedNCT01902615
- A Study of the Drug-Drug Interaction of RO5503781 and Posaconazole, the Relative Bioavailability of New Formulations of RO5503781 and the Food-Effect on the Pharmacokinetics of RO5503781 in Patients With Solid TumorsCompletedNCT01901172Phase 1
- A Study of RO4995819 to Assess Bioavailability and Safety in Healthy VolunteersCompletedNCT01901159Phase 1
- An Open-Label Study of Zelboraf (Vemurafenib) in Patients With Braf V600 Mutation Positive Metastatic MelanomaCompletedNCT01898585Phase 4
- A Safety, Tolerability, and Pharmacokinetics Study of Onartuzumab as Single Agent or in Combination With Sorafenib in Participants With Advanced Hepatocellular CarcinomaCompletedNCT01897038Phase 1
- A Study of RO6799477 in Healthy VolunteersCompletedNCT01893437Phase 1
- An Observational Study of Avastin (Bevacizumab) in Elderly Patients With Non-Squamous Non-Small Cell Lung Cancer in Clinical PracticeCompletedNCT01893268
- A Non-Interventional Study in Patients With Rheumatoid Arthritis Who Are Treated With RoActemra/Actemra (Tocilizumab)WithdrawnNCT01893255
- A Study of Alegitazar in Patients With Type 2 Diabetes And Chronic Kidney Disease (Alerenal Study)WithdrawnNCT01893242Phase 3
- A Non-Interventional Study of Mircera (Methoxy Polyethylene Glycol-Epoetin Beta) in Patients With Chronic Kidney Disease Not on DialysisNo longer availableNCT01892202
- A Study of Onartuzumab in Combination With Erlotinib in Patients With MET-Positive Stage IIIB or IV Non-Small Cell Lung Cancer Carrying an Activating Epidermal Growth Factor Receptor (EGFR) MutationCompletedNCT01887886Phase 3
- A Study of The Effect of RoActemra/Actemra (Tocilizumab) in Combination With Methotrexate on Articular Damage in The Hand in Patients With Moderate to Severe Rheumatoid Arthritis Who Have an Inadequate Response to Non-Biological DMARDsWithdrawnNCT01878318Phase 4
- Study of RXDX-105, Potent RET Inhibitor in Patients With Advanced Lung Cancer and Other Solid TumorsCompletedNCT01877811Phase 1
- A Study of MHAA4549A to Assess Safety And Pharmacokinetics in Healthy VolunteersCompletedNCT01877785Phase 1
- A Dose-Escalation Study of GDC-0994 in Patients With Locally Advanced or Metastatic Solid TumorsCompletedNCT01875705Phase 1
- A Study of Three Modified-Release Formulations of RO4917523 in Healthy VolunteersCompletedNCT01873508Phase 1
- A Study of Aleglitazar in Monotherapy in Patients With Type 2 Diabetes Mellitus Who Are Drug-Naïve to Anti-Hyperglycemic TherapyCompletedNCT01871428Phase 3
- A Study of Aleglitazar in Combination With Metformin in Patients With Type 2 Diabetes Mellitus Who Are Inadequately Controlled With Metformin MonotherapyCompletedNCT01871415Phase 3
- A Study of Lebrikizumab in Participants With Uncontrolled Asthma on Inhaled Corticosteroids and a Second Controller MedicationCompletedNCT01868061Phase 3
- A Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of RO5545965 in Healthy VolunteersCompletedNCT01864226Phase 1
- An Observational Study of Avastin (Bevacizumab) in Combination With Chemotherapy as First-Line Treatment in Patients With Advanced Ovarian Cancer (OSCAR 1)CompletedNCT01863693
- A Dose-escalation Study to Assess the Safety, Tolerability, and Pharmacokinetics of GDC-0032 in Combination With Docetaxel or With Paclitaxel in Patients With HER2-negative Locally Recurrent or Metastatic Breast Cancer or Non-small Cell Lung CancerCompletedNCT01862081Phase 1